Literature DB >> 33073327

Masked malignant phenotype with a benign appearance: beat-up copy number profile may be the key for hemangioblastoma dissemination.

Soichi Oya1, Shunsaku Takayanagi2, Hirokazu Takami2, Masahiro Indo3, Takahisa Yamashita4, Nobuhito Saito2, Toru Matsui3.   

Abstract

Dissemination of histologically benign hemangioblastoma is rare; approximately 30 cases have previously been reported, and all cases occurred several months to years after surgical resection. Herein, we report a case of hemangioblastoma in which leptomeningeal dissemination occurred 2 years after hypofractionated radiation therapy (39 Gy/13 fractions). The tumor was treated primarily with radiation without surgical resection. Biopsy of the disseminated lesion confirmed histological diagnosis as histologically benign hemangioblastoma. Ki67 index was not remarkably elevated for hemangioblastomas. In addition, the methylation class determined by the methylation profiling classifier developed by the German Cancer Research Center (DKFZ)/University Hospital Heidelberg/German Consortium for Translational Cancer Research was consistent with that of common hemangioblastomas. However, genetic analyses showed significant gains and losses throughout the whole genome, indicating that highly aberrant copy number profiles may be the key to elucidating this rare but life-threatening clinical entity. Accumulation of more detailed case reports based on the comparison of specimens obtained before and after surgery or radiation is necessary to better understand the pathophysiology of the dissemination phenotype of hemangioblastoma.

Entities:  

Keywords:  Copy number aberration; Dissemination; Hemangioblastoma; Methylation

Mesh:

Year:  2020        PMID: 33073327     DOI: 10.1007/s10014-020-00387-7

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  5 in total

1.  Leptomeningeal hemangioblastomatosis in a case of von Hippel-Lindau disease: case report.

Authors:  Nicolas Reyns; Richard Assaker; Etienne Louis; Jean-Paul Lejeune
Journal:  Neurosurgery       Date:  2003-05       Impact factor: 4.654

2.  Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.

Authors:  J E Conway; D Chou; R E Clatterbuck; H Brem; D M Long; D Rigamonti
Journal:  Neurosurgery       Date:  2001-01       Impact factor: 4.654

3.  A Case of Holocord Leptomeningeal Dissemination from Cerebellar Hemangioblastoma without von Hippel-Lindau Disease.

Authors:  Hideo Ohba; Satoshi Yamaguchi; Takuro Magaki; Masaaki Takeda; Manish Kolakshyapati; Takashi Sadatomo; Kaoru Kurisu
Journal:  Hiroshima J Med Sci       Date:  2017-03

4.  [A case of hemangioblastoma with subarachnoid dissemination].

Authors:  T Tohyama; O Kubo; R Kusano; N Miura; H Himuro
Journal:  No Shinkei Geka       Date:  1990-01

5.  Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas.

Authors:  H Kanno; K Kondo; S Ito; I Yamamoto; S Fujii; S Torigoe; N Sakai; M Hosaka; T Shuin; M Yao
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.